Advertisement

Autoimmune Retinopathy

  • Karen R. Armbrust
  • Maggie M. Wei
  • Brett G. Jeffrey
  • H. Nida Sen
Living reference work entry

Abstract

Non-paraneoplastic autoimmune retinopathy (AIR) typically presents in middle-aged females with vision loss, visual field loss, electroretinography (ERG) changes, and positive anti-retinal antibody testing, often in the context of an unremarkable fundus examination. Fundus autofluorescence (FAF) and optical coherence tomography (OCT) may be helpful ancillary tests in AIR. Evaluation for underlying malignancy with the patient’s primary care provider is essential to rule out a paraneoplastic retinopathy.

Keywords

Optical Coherence Tomography Visual Field Loss Photoreceptor Layer Fundus Autofluorescence Ellipsoid Zone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Abazari A, Allam SS, Adamus G, Ghazi NG. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012;153(4):750–6, 6 e1.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:5.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Faez S, Loewenstein J, Sobrin L. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol. 2013;131(1):113–5.CrossRefPubMedGoogle Scholar
  4. Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, et al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol. 2016;168:183–90.CrossRefPubMedGoogle Scholar
  5. Forooghian F, Macdonald IM, Heckenlively JR, Heon E, Gordon LK, Hooks JJ, et al. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008;146(4):489–95.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157(2):266–72. e1.CrossRefPubMedGoogle Scholar
  7. Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina. 2014;34(5):827–45.CrossRefPubMedGoogle Scholar
  8. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127(5):565–73.CrossRefPubMedGoogle Scholar
  9. Lima LH, Greenberg JP, Greenstein VC, Smith RT, Sallum JM, Thirkill C, et al. Hyperautofluorescent ring in autoimmune retinopathy. Retina. 2012;32(7):1385–94.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol. 2008;28(1):5–11.CrossRefPubMedGoogle Scholar
  11. Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol. 2005;139(5):780–94.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India (outside the USA) 2016

Authors and Affiliations

  • Karen R. Armbrust
    • 1
  • Maggie M. Wei
    • 1
  • Brett G. Jeffrey
    • 2
  • H. Nida Sen
    • 1
  1. 1.Laboratory of ImmunologyNational Eye Institute, National Institutes of HealthBethesdaUSA
  2. 2.Ophthalmic Genetics and Visual Function BranchNational Eye Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations